Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets

Out-
      side
 

Personalized protocols (age, gender, body habitus, etc.) lead to :
more automated planning 
improved patient comfort 
better diagnostics 
optimized image quality 
nothing 




 
MRI News Service:
'Food and Drug Administration'  p6
SEARCH NEWS FOR   
 
Result: Searchterm 'Food and Drug Administration' found in 73 news
Result Pages
...
More Results: Database  (9)  
News     News Refinements:  Contrast Agents  Devices  Financial  
FDA Advisory Committee Recommends Approval of Bayer Corporation (BAY)'s Gadobutrol Injection for MRI of the Central Nervous System
'''''Bayer HealthCare Pharmaceuticals Inc. announced today that the Peripheral and Central Nervous System Drugs Advisory Committee to the U.S. Food and Drug Administration (FDA) voted unanimously that clinical trial and postmarketing data for gadobutrol ...'
Friday, 21 January 2011   by www.biospace.com
Covidien Supports FDA's Patient Safety Efforts for Gadolinium-Based Contrast Agents
'''''Covidien (NYSE:COV), a leading global provider of healthcare products, today announced it supports the U.S. Food and Drug Administration's (FDA) labeling changes for gadolinium-based contrast agents for patients with acute kidney injury or chronic, ...'
Friday, 10 September 2010   by investor.covidien.com
Lantheus Medical Imaging, Inc. Commends Safety Labeling Changes Announced by U.S. Food and Drug Administration for Gadolinium-Based Contrast Agents
''''' Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, supports the U.S. Food and Drug Administration's (FDA) announcement requiring safety-related label changes for all gadolinium-based contrast agents to highlight the rare ...'
Friday, 10 September 2010   by www.radiopharm.com
FDA: New warnings required on use of gadolinium-based contrast agents
'''''The U.S. Food and Drug Administration is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of a rare and potentially fatal condition known as nephrogenic systemic fibrosis (NSF), if the drug is ...'
Thursday, 9 September 2010   by www.fda.gov
FDA Accepts New Drug Application For Gadovist® 1.0 Injection In Magnetic Resonance Imaging
'''''Bayer Schering Pharma AG, Berlin, Germany, announced today that the Food and Drug Administration (FDA) has accepted for filing a New Drug Application to the U.S. for gadobutrol injection, a gadolinium-based contrast agent for magnetic resonance ...'
Friday, 6 August 2010   by www.medicalnewstoday.com
FDA Accepts New Drug Application for Gadovist® 1.0 Injection in Magnetic Resonance Imaging
'''''Bayer Schering Pharma AG, Berlin, Germany, announced today that the Food and Drug Administration (FDA) has accepted for filing a New Drug Application to the U.S. for gadobutrol injection, a gadolinium-based contrast agent for magnetic resonance ...'
Wednesday, 4 August 2010   by viva.vita.bayerhealthcare.de
Key Alzheimer's Drug Development Stakeholders Join Forces To Establish Clinical Trial Safeguards And Accelerate Discovery
'''''New recommendations to protect participant safety in clinical trials of certain Alzheimer's disease drugs have been accepted by the U.S. Food and Drug Administration (FDA) and are already being incorporated into research studies. These safety ...'
Monday, 12 July 2010   by www.prnewswire.com
Medtronic's Study in Trouble
'''''Medtronic Inc. (MDT - Analyst Report) has received several complaints from the U.S. Food and Drug Administration (FDA) regarding the company's study of a new pacemaker that can be used in a Magnetic Resonance Imaging (MRI) machine. The FDA has raised ...'
Wednesday, 17 March 2010   by www.zacks.com
FDA Advised to Tighten Restrictions on GE and Covidien MRI Drugs
'''''Most members of a federal advisory panel recommended Tuesday that the Food and Drug Administration effectively ban, for patients with severe kidney disease, the use of two drugs used to create high-contrast images on magnetic resonance imaging (MRI) ...'
Wednesday, 9 December 2009   by www.propublica.org
UPDATE 2-US FDA sees varying risk from MRI agents
'''''Some contrast agents used with magnetic resonance imaging scans appear to carry a higher risk of a potentially fatal skin disease than others, U.S. drug reviewers said in documents released on Tuesday. The Food and Drug Administration said a staff ...'
Tuesday, 17 November 2009   by www.reuters.com
News     News Refinements:  Contrast Agents  Devices  Financial  
Radiology News Open this link in a new window Ultrasound Imaging News Open this link in a new window
Result Pages
...
Money is like a sixth sense without which you cannot make a complete use of the other five.
- W. Somerset Maugham
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 8 May 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]